These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands. Vermaas M, Gosselink MP, Ferenschild FT, van den Aardweg E, Lont HE, Kemperman HW, van der Harst E, Tetteroo GW, Oostenbroek RJ, Dijkhuis CM, Eggermont AM, de Wilt JH. Eur J Surg Oncol; 2007 Sep; 33(7):862-7. PubMed ID: 17257804 [Abstract] [Full Text] [Related]
8. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam. Visser O, Bakx R, Zoetmulder FA, Levering CC, Meijer S, Slors JF, van Lanschot JJ. J Surg Oncol; 2007 May 01; 95(6):447-54. PubMed ID: 17048237 [Abstract] [Full Text] [Related]
11. Quality assurance in rectal cancer treatment. van de Velde CJ, van den Broek CB. Dig Dis; 2012 May 01; 30 Suppl 2():126-31. PubMed ID: 23207944 [Abstract] [Full Text] [Related]
18. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer]. Wu AW, Gu J, Wang J. Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May 01; 9(3):207-9. PubMed ID: 16721678 [Abstract] [Full Text] [Related]
20. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. den Dulk M, Marijnen CA, Putter H, Rutten HJ, Beets GL, Wiggers T, Nagtegaal ID, van de Velde CJ. Ann Surg; 2007 Jul 01; 246(1):83-90. PubMed ID: 17592295 [Abstract] [Full Text] [Related] Page: [Next] [New Search]